This inventor holds 4 USPTO granted patents. Top assignee: Lupin Laboratories Limited. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madhya Pradesh, IN (1998)
- Mandideep, IN (1998 - 1999)
- Mandideep, Dist. Raisen, M.P., IN (1999)
Company Filing History:
Years Active: 1998-1999
Title: Debashish Datta: Innovator in Cephalosporin Manufacturing
Introduction
Debashish Datta is a notable inventor based in Mandideep, India. He has made significant contributions to the field of pharmaceuticals, particularly in the manufacturing of cephalosporin antibiotics. With a total of 4 patents to his name, Datta's work has had a considerable impact on antibiotic production.
Latest Patents
Among his latest patents is a method for the manufacture of cephalosporin and intermediates thereof. This invention focuses on reactive derivatives of 2-(2-aminothiazol-4-yl)-2-methoxyimino acetic acid and 1H-tetrazol-1-acetic acid. The general formula I outlines the use of these derivatives in the production of cephalosporin antibiotics such as cefotaxime, ceftriaxone, and cefazolin.
Career Highlights
Debashish Datta is currently associated with Lupin Laboratories Limited, a prominent player in the pharmaceutical industry. His expertise in antibiotic manufacturing has positioned him as a key figure in the development of innovative solutions in this field.
Collaborations
Datta has worked alongside talented colleagues, including Bishwa Prakash Rai and Vinod George. Their collaborative efforts have contributed to the advancement of pharmaceutical technologies and the enhancement of antibiotic production processes.
Conclusion
Debashish Datta's contributions to the field of pharmaceuticals, particularly in cephalosporin manufacturing, highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing antibiotic production, making a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile